CapsoVision Inc (CV)

Currency in USD
7.01
-0.05(-0.71%)
Closed·
7.010.00(0.00%)
·
Earnings results expected in 7 days
CV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.597.16
52 wk Range
3.4315.37
Key Statistics
Prev. Close
7.06
Open
7.14
Day's Range
6.59-7.16
52 wk Range
3.43-15.37
Volume
77.06K
Average Volume (3m)
304.2K
1-Year Change
-
Book Value / Share
0.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.50
Upside
+49.79%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

CapsoVision Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.50
(+49.79% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Benchmark
Buy10.00+42.65%14.00Maintain27/03/2026
Roth/MKM
Buy11.00+56.92%7.00Maintain23/03/2026
Benchmark
Buy14.00+99.71%5.00Maintain31/12/2025
Benchmark
Buy5.00-28.67%5.00Maintain14/11/2025

CapsoVision Inc Earnings Call Summary for Q4/2025

  • CapsoVision Q4 2025 revenue rose 13% YoY to $3.9M; full-year growth reached 15% driven by CapsoCam Plus capsule sales.
  • Operating expenses surged 49% YoY to $9.4M due to investments in CMOS sensors and clinical studies, pressuring profitability.
  • Stock declined 8.95% to $8.27 in after-hours trading on negative earnings outlook; EPS at -$1.69 despite 136% annual return.
  • Company completed $14M private placement, boosting cash position to $24.1M to fund strategic initiatives and market expansion.
  • Analysts maintain bullish outlook with price targets of $11-$14, though stock trades at elevated 17.26x Price/Book multiple.
Last Updated: 26/03/2026, 21:12
Read Full Transcript

Earnings

Latest Release
26/03/2026
EPS / Forecast
-0.16 / -0.10
Revenue / Forecast
3.9M / --
EPS Revisions
Last 90 days

Compare CV to Peers and Sector

Metrics to compare
CV
Peers
Sector
Relationship
P/E Ratio
−13.8x−4.1x−0.5x
PEG Ratio
−0.15−0.170.00
Price/Book
26.4x2.8x2.6x
Price / LTM Sales
25.8x2.1x3.2x
Upside (Analyst Target)
49.4%44.1%48.3%
Fair Value Upside
Unlock9.3%5.6%Unlock

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.38M4.78%16.82M
Other Institutional Investors
1.85M3.72%13.09M
Public Companies & Retail Investors
45.61M91.50%322.03M
Total
49.85M100.00%351.94M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kioxia Holdings Corporation6.91%3,446,92524,335
Vanguard Index Funds - Vanguard Total Stock Market ETF1.86%925,2006,532

People Also Watch

27.87
DSGR
-0.50%
1.13
SOWG
-18.77%
1.24
FLD
-3.88%
3.610
ADAG
-0.28%

FAQ

What Is the CapsoVision (NASDAQ: CV) Share Price Today?

The CapsoVision stock price today is 7.01 USD.

What Stock Exchange Does CapsoVision (CV) Trade On?

CapsoVision is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for CapsoVision?

The stock symbol (also called a 'ticker') for CapsoVision is "CV."

What Is the Current CapsoVision Market Capitalisation?

As of today, CapsoVision (NASDAQ: CV) market cap is 351.94M USD.

What Is CapsoVision's (CV) Earnings Per Share (TTM)?

The CapsoVision EPS is currently -1.03 (Trailing Twelve Months).

When Is the Next CapsoVision Earnings Date?

CapsoVision's next earnings report will be released on 14/05/2026.

Is CV a Buy or Sell From a Technical Analyst Perspective?

Based on today's CapsoVision moving averages and other technical indicators, the daily buy/sell signal for CV stock is Strong Buy.

How Many Times Has CapsoVision Stock Split?

CapsoVision has split 0 times. (See the CV stock split history page for full effective split date and price information.)

How Many Employees Does CapsoVision Have?

CapsoVision has 99 employees, based on their latest Companies House report.

What is the current trading status of CapsoVision (NASDAQ: CV)?

As of 07/05/2026, CapsoVision (CV) is trading at a share price of 7.01 USD, with a previous close of 7.06 USD. The stock has fluctuated within a day range of 6.59 USD to 7.16 USD, while its 52-week range spans from 3.43 USD to 15.37 USD.

What Is CapsoVision (CV) Price Target According to Analysts?

The average 12-month price target for CapsoVision is 10.50 USD, with a high estimate of 11 USD and a low estimate of 10 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +49.79% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.